Successful treatment of gynecologic malignancy with trastuzumab deruxtecan in three patients with HER2 mutations.

Saved in:
Bibliographic Details
Title: Successful treatment of gynecologic malignancy with trastuzumab deruxtecan in three patients with HER2 mutations.
Authors: Choudhury DS; Pritzker School of Medicine, University of Chicago, Chicago, IL, USA., Kurnit KC; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago Medical Center, Chicago, IL, USA., Yamada SD; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago Medical Center, Chicago, IL, USA., Lee NK; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago Medical Center, Chicago, IL, USA., Vemuri A; Department of Pathology, University of Chicago Medical Center, Chicago, IL, USA., Barroeta JE; Department of Pathology, University of Chicago Medical Center, Chicago, IL, USA., Rayani S; Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, USA., Straus CM; Department of Radiology, University of Chicago Medical Center, Chicago, IL, USA., Fleming GF; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago Medical Center, Chicago, IL, USA.; Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, USA., Kim JS; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago Medical Center, Chicago, IL, USA.
Source: Gynecologic oncology reports [Gynecol Oncol Rep] 2025 Oct 13; Vol. 62, pp. 101974. Date of Electronic Publication: 2025 Oct 13 (Print Publication: 2025).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101652231 Publication Model: eCollection Cited Medium: Print ISSN: 2352-5789 (Print) Linking ISSN: 23525789 NLM ISO Abbreviation: Gynecol Oncol Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2352-5789
DOI:10.1016/j.gore.2025.101974